Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blend Labs, Inc. (NYSE: BLND) files reports with the U.S. Securities and Exchange Commission as a Delaware corporation in the software publishers industry. On this BLND SEC filings page, Stock Titan aggregates the company’s regulatory disclosures, including current reports on Form 8-K and other periodic filings, and applies AI-powered summaries to help explain their contents in plain language.
Blend’s 8-K filings illustrate the types of material events the company reports to regulators and investors. Recent examples include the announcement of quarterly financial results, where Blend discusses software platform and professional services revenue, GAAP and non-GAAP gross margins, operating income or loss, and key operating metrics. Other 8-K filings cover leadership and executive transitions, such as changes in the Head of Finance and Administration role and related transition agreements, as well as appointments like the Head of Revenue.
Investors can also use this page to locate references to non-GAAP financial measures and the adjustments Blend applies, including stock-based compensation, workforce reduction costs, facilities-related charges, compensation realignment, litigation contingencies, transaction-related costs, software amortization and impairment, executive transition costs, and other items. These details are important for understanding how the company presents measures such as non-GAAP operating income and operating margin alongside GAAP results.
Stock Titan’s interface is designed to make it easier to work through Blend’s SEC disclosures. Users can quickly access quarterly and annual reports when available, review 8-K filings about results of operations, and see filings related to corporate governance or compensation matters. AI-generated highlights help surface the main points of each filing, including financial performance, key agreements, and leadership changes, so readers can navigate Blend’s regulatory history more efficiently.
Ling Winnie reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs, Inc. reported that its Head of Legal and People, Winnie Ling, received equity awards in the form of restricted stock units. She was granted 313,312 Restricted Stock Units, which will vest in equal quarterly installments over two years while she remains a service provider.
She also received 78,328 Performance-based Restricted Stock Units. These are eligible to vest in four equal tranches based on the company’s stock price performance through December 31, 2029, again conditioned on her continued service.
Ghamsari Nima reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs, Inc. reported that Head of Blend and director Nima Ghamsari received equity awards in the form of restricted stock units. He was granted 913,832 Restricted Stock Units, each representing a contingent right to one share of BLND Class A common stock.
The RSUs vest in equal quarterly installments over two years, as long as he continues as a service provider. He also received 913,836 performance-based RSUs, which can vest in four equal tranches based on the company’s stock price performance through December 31, 2029, with continued service required.
Blend Labs, Inc. executive Brian Kneafsey, Head of Revenue, reported a planned sale of company stock. On January 15, 2026, he sold 25,000 shares of Blend Labs Class A common stock at an average price of $3.0568 per share, as disclosed in a Form 4 insider trading report. The transaction was executed under a Rule 10b5-1 trading plan that he adopted on March 14, 2025, which is designed to allow pre-scheduled trades. After this sale, he beneficially owns 649,824 shares of Class A common stock directly.
Blend Labs, Inc. insider Brian Kneafsey has filed a notice of proposed sale of 100,000 shares of common stock, to be sold through Charles Schwab & Co., Inc. on the NYSE, with an approximate sale date of 01/15/2026. The filing lists an aggregate market value for this planned sale of $305,680.00, compared with 256,119,535 shares outstanding of Blend Labs common stock. These 100,000 shares were acquired on 02/17/2020 through an exercise-and-hold transaction paid in cash. Over the past three months, Kneafsey has already sold three blocks of 25,000 Blend Labs shares each, generating gross proceeds of $83,509.00, $74,732.00, and $76,486.00.
Blend Labs, Inc. Principal Accounting Officer Oxana Tkach reported selling 2,500 shares of Class A common stock on January 7, 2026 at a price of $3.09 per share. This was a routine insider transaction reported on a Form 4.
After this sale, Tkach beneficially owned 77,017 shares of Blend Labs Class A common stock in direct ownership. The filing states that the sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on September 9, 2025, which is designed to allow insiders to sell shares according to a preset schedule.
Blend Labs has a planned sale of restricted shares under Rule 144. A shareholder filed notice to sell 2,500 shares of common stock through Charles Schwab on or about January 7, 2026 on the NYSE, with an indicated aggregate market value of $7,725.00.
The shares were originally acquired from Blend Labs, Inc. on May 20, 2025 through a restricted stock lapse as equity compensation. As of the filing, Blend Labs reported 256,119,535 shares of common stock outstanding, which is a baseline ownership figure rather than the amount being sold.
Blend Labs, Inc. reported that Matt Thomson has joined the company as Head of Revenue. The company disclosed this leadership change in connection with a press release dated January 6, 2026, which is included as an exhibit. The filing does not discuss financial results, but focuses on announcing this senior revenue-focused appointment.
Blend Labs, Inc. reported that its Head of Revenue, an officer of the company, sold 25,000 shares of Class A common stock on 12/15/2025 at a weighted average price of $3.0594 per share. The sale was made under a Rule 10b5-1 trading plan adopted on March 14, 2025, and the officer continues to directly own 674,824 shares after the transaction.
An individual named Brian Kneafsey has filed a notice to sell 25,000 shares of Blend Labs, Inc. common stock. The shares are to be sold through Charles Schwab & Co., Inc. on or about 12/15/2025 on the NYSE, with an aggregate market value listed as $76,486.00.
The notice states these shares were acquired on 02/17/2020 in an “Exercise and Hold” transaction from Blend Labs, Inc. for cash. It also discloses prior sales by the same seller over the past three months of 25,000 shares each on 09/15/2025, 10/15/2025, and 11/17/2025, with gross proceeds of $109,069.00, $83,509.00, and $74,732.00, respectively.
Blend Labs, Inc. insider entities affiliated with investor Brian N. Sheth, who is a director and 10% owner, reported open-market purchases of Class A common stock. On December 1, 2025, they bought 430,531 shares at a weighted average price of $3.1405 per share. On December 2, 2025, they acquired 345,404 shares at a weighted average of $3.0883, and on December 3, 2025, 533,888 shares at a weighted average of $3.0904.
After these transactions, 10,848,873 shares of Class A common stock were beneficially owned indirectly through Haveli Brooks Aggregator, L.P., and an additional 130,000 shares were held through a family trust for which Mr. Sheth’s spouse serves as trustee. The filing notes that the reported prices are weighted averages for multiple trades within narrow price ranges, and that full trade details are available upon request.